Vilanterol trifenatate

Overview

Vilanterol (GW642444) trifenatate is a long-acting β 2 adrenergic receptor agonist. Vilanterol trifenatate has pEC 50 values for β 2 -AR, β 1 -AR, and β 3 -AR of 9.4, 6.4, and 6.1, respectively. Vilanterol trifenatate selectively activates airway β 2 adrenergic receptors, increases cAMP and thus relaxes bronchial smooth muscle. Vilanterol trifenatate can be used in asthma research [2][4] .

Application

Products | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Depression | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Obesity | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Endocrinology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Adrenergic Receptor

Product Information

• Catalog No.: HY-14300A
• CAS No.: 503070-58-4
• Molecular Formula: C44H49Cl2NO7
• Molecular Weight: 774.77
• Purity: 99.82%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: 2 mg/mL (2.58 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source